CLINICAL_TRIALS ClinicalTrials.gov record update

MAGNITUDE-2: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06672237
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:29:09.509879+00:00
Published At: 2026-04-16T00:00:00+00:00
Record Updated At: 2026-04-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neuromuscular Disease", "Neuromuscular Diseases (NMD)", "Neurodegenerative Disease", "Neurodegenerative Disease, Hereditary", "Neurodegenerative Diseases", "Neuromuscular Diseases", "Nerve Disorders", "Nervous System Disease", "Nervous System Diseases", "Genetic Disease, Inborn", "Amyloidosis, Familial", "Amyloidosis, Hereditary", "Amyloidosis", "Polyneuropathies", "Amyloid Neuropathies", "Amyloid Neuropathies, Familial", "Peripheral Nervous System Disease", "Peripheral Nervous System Diseases", "Metabolism, Inborn Errors", "Metabolic Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-04-16"
protocolSection.identificationModule.nctId: "NCT06672237"
protocolSection.identificationModule.officialTitle: "MAGNITUDE-2: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN)"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.